MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS
OH W, KANTOFF P. MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER: CURRENT STANDARDS AND FUTURE PROSPECTS. Journal Of Urology 1998, 160: 1220-1229. PMID: 9751323, DOI: 10.1016/s0022-5347(01)62501-1.Peer-Reviewed Original ResearchConceptsTreatment of hormone refractory prostate cancerHormone refractory prostate cancerRefractory prostate cancerBiology of hormone refractory prostate cancerSecondary hormonal therapyProstate cancerHormone therapyProstate specific antigen valuesAntiandrogen withdrawal responsePhase II studyMeasurement of response to therapyResponse to therapyClinical trial endMeasure response to treatmentResponse to treatmentMEDLINE literature searchCombination of drugsClinical trial interpretationAvailability of agentsAlternative antiandrogenEstramustine combinationsPalliative capabilitiesClinical responsePalliative benefitII studyMANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER
OH W, KANTOFF P. MANAGEMENT OF HORMONE REFRACTORY PROSTATE CANCER. Journal Of Urology 1998, 160: 1220-1229.. DOI: 10.1097/00005392-199810000-00003.Peer-Reviewed Original ResearchTreatment of hormone refractory prostate cancerHormone refractory prostate cancerRefractory prostate cancerBiology of hormone refractory prostate cancerSecondary hormonal therapyProstate cancerHormone therapyProstate specific antigen valuesAntiandrogen withdrawal responsePhase II studyMeasurement of response to therapyResponse to therapyClinical trial endResponse to treatmentMeasure response to treatmentMEDLINE literature searchCombination of drugsClinical trial interpretationAvailability of agentsAlternative antiandrogenEstramustine combinationsPalliative capabilitiesClinical responsePalliative benefitII study
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply